Y10S 930/17
Vasoactive intestinal peptides
Official title: Vasoactive intestinal peptides; related peptides
Y10S930/17 (Vasoactive intestinal peptides) appears on 23 US grants and 3 published applications in this corpus.
Search patents in Y10S- Granted patents
- 23
- Published applications
- 3
- Assignees
- 13
- Inventors
- 41
- Latest grant
- 5 Jun 2007
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists5 Jun 2007US 7,226,910 B2Vivus, Inc.
- Vasoactive intestinal peptide analogs22 Aug 2006US 7,094,755 B2Dabur Research Foundation
- Vasoactive intestinal peptide analogs3 Dec 2002US 6,489,297 B1Dabur Research Foundation
- Cyclic vasoactive peptide analogs14 Oct 1997US 5,677,419 AHoffmann-La Roche Inc.
- Method of producing 2 KD to 10 KD peptides having no L-methionine residue31 May 1994US 5,316,919 A
- Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists23 Feb 2006US 2006/0041021 A1Vivus, Inc.
- Vasoactive intestinal peptide analogs21 Aug 2003US 2003/0158110 A1Dabur Research Foundation
- Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof25 Jul 2002US 2002/0099003 A1
Most cited
By later US patents
- Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists99US 7,226,910 B2Vivus, Inc. · 2007
- VIP type peptides38US 4,737,487 ABeecham Group Limited · 1988
- Synthetic vasoactive intestinal peptide analogs33US 4,605,641 AHoffmann-La Roche Inc. · 1986
- Hypothalamic polypeptides with adenylate cyclase stimulating activity29US 5,128,242 AThe Administrators of the Tulane Educational Fund · 1992
- Derivatives of A-30912A nucleus23US 4,320,052 AEli Lilly and Company · 1982